EHA 2015: Ongoing data from the phase 3 RESPONSE trial of ruxolitinib for polycythemia vera

At the 20th Congress of the European Hematology Association (EHA), Claire Harrison, MD, DM, FRCP, FRCPath, of Guy's and St Thomas' NHS Foundation Trust, London, UK, provides an update on the ongoing, ... Author: VJHemOnc Added: 07/27/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts